John Heymach

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

John Heymach

Mar 5, 2025, 16:21 | Science

Eric Singhi: Phase 1a study of zongertinib in metastatic solid tumors with HER2 alterations

Eric Singhi, Assistant Professor in the Department of General Oncology at The University of Texas…

Jan 14, 2025, 18:02 | Insight

MD Anderson Research Highlights

Featuring molecular insights into cancer cell progression, novel predictive biomarkers for multiple cancer types, and…

Oct 12, 2024, 15:19 | Insight

Nathan Pennell: Incredible effort from investigators all over the world on this paper

A recent paper by Ferdinandos Skoulidis et al. was published in Nature Journal. "CTLA4 blockade…

Oct 5, 2024, 23:43 | Insight

MD Anderson Research Highlights for the 2024 World Conference on Lung Cancer

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent…

Jul 6, 2024, 13:16 | Blog

Wafik El-Deiry about DAVA Oncology 3rd Global Thoracic Malignancies Summit

Wafik El-Deiry shared posts on LinkedIn and X: . "Grateful for opportunity to speak about…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023